Amarantus BioScience, Avant Diagnostics deal

Avant acquired Amarantus BioScience’s Amarantus Diagnostics Inc. subsidiary for 80 million shares of Avant stock valued at $25.6 million based on Avant’s close of $0.32 on May 11, the day before the d...